| Kaylee Nickole Janet Bauserman, | |
|
7209 N Shadeland Ave, Indianapolis, IN 46250-2021 | |
| (317) 288-7606 | |
| Not Available |
| Full Name | Kaylee Nickole Janet Bauserman |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 7209 N Shadeland Ave, Indianapolis, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023688165 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kaylee Nickole Janet Bauserman, 7209 N Shadeland Ave, Indianapolis, IN 46250-2021 Ph: (317) 288-7606 | Kaylee Nickole Janet Bauserman, 7209 N Shadeland Ave, Indianapolis, IN 46250-2021 Ph: (317) 288-7606 |
News Archive
Marin Institute, the alcohol industry watchdog, released a report today criticizing the hasty approval of two beer mergers that left 80 percent of the United States beer market in the hands of two foreign companies - MillerCoors and Anheuser-Busch InBev. Big Beer Duopoly: A Primer for Policymakers and Regulators describes the drastic shift in U.S. beer market ownership to this powerful duo of global corporations.
Detecting hidden genetic defects by applying an existing method to an existing datasets. Researchers at Radboud university medical center have succeeded.
BIOTRONIK, a leading European manufacturer of therapy solutions for vascular intervention, announced the completion of enrollment in the BIOLUX P-I - a clinical study investigating the use of a drug-eluting balloon (DEB) catheter, a promising new approach to treating disease in the more challenging peripheral vascular anatomy.
"A global initiative to rid the world of polio launched an emergency action plan on Thursday because gaps in funding and vaccination coverage threaten to derail a final push towards stamping out the paralyzing disease," AlertNet reports.
A new and promising class of chemical compounds has major potential for treating Zika virus and respiratory syncytial virus, or RSV, according to a new study by University of Alberta scientists. The next step is to develop a drug.
› Verified 7 days ago
Mrs. Rachelle Lyn Ferguson, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8616 W 10th St, Indianapolis, IN 46234 Phone: 317-209-2332 | |
Anne P Droese, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6923 Hillsdale Ct, Indianapolis, IN 46250 Phone: 317-472-6150 Fax: 317-644-8050 | |
Mrs. Samantha Lonetta Rae Hannah, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8921 Southpointe Dr, Suite C-1, Indianapolis, IN 46227 Phone: 317-881-1718 Fax: 317-881-1728 | |
Ms. Courtney Elese Gorbandt, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6239 S East St Ste A, Indianapolis, IN 46227 Phone: 317-791-9031 | |
Julia Porter, MSP, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 8111 S Emerson Ave, Indianapolis, IN 46237 Phone: 317-528-8111 | |
Sarah Dixon, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8111 S Emerson Ave, Indianapolis, IN 46237 Phone: 317-528-8111 | |
Mrs. Yvette Renee White, MS,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3647 Branch Way, Indianapolis, IN 46268 Phone: 317-989-2229 Fax: 317-871-2867 |